Drug Type Bispecific antibody |
Synonyms |
Target |
Mechanism IFN inhibitors(interferon alpha 1 inhibitors), TNF inhibitors(Tumor necrosis factor inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Crohn Disease | Preclinical | KR | 01 Nov 2024 |